{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:06:49Z","timestamp":1789092409637,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.coi.2026.102834","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:48:38Z","timestamp":1789087718000},"page":"102834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A systematic review of juvenile dermatomyositis complicated by macrophage activation syndrome"],"prefix":"10.1016","volume":"103","author":[{"given":"Martina","family":"Rossano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Vaienna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Brusadelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"La Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Filocamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Minoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102834_bib1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","article-title":"The incidence of juvenile dermatomyositis: results from a nation-wide study","volume":"34","author":"Symmons","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102834_bib3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/jpc.15595","article-title":"Incidence, severity and clinical manifestations of juvenile dermatomyositis among Maori and Pacific Island compared to European children","volume":"57","author":"Concannon","year":"2021","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.coi.2026.102834_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.15379","article-title":"Incidence and outcomes for children with idiopathic inflammatory myopathy in Western Australia: a long-term population-based study","volume":"27","author":"Nossent","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.coi.2026.102834_bib5","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/B978-0-444-59565-2.00014-9","article-title":"Juvenile dermatomyositis","volume":"113","author":"Quartier","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.coi.2026.102834_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-025-01146-8","article-title":"Juvenile dermatomyositis: new insights into pathogenesis and clinical applications","volume":"23","author":"Chan Ng","year":"2025","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.coi.2026.102834_sbref7","doi-asserted-by":"crossref","DOI":"10.3390\/children11091046","article-title":"Advances in juvenile dermatomyositis: pathophysiology, diagnosis, treatment and interstitial lung diseases\u2014a narrative review","volume":"11","author":"Kobayashi","year":"2024","journal-title":"Children"},{"key":"10.1016\/j.coi.2026.102834_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/art.43052","article-title":"Macrophage activation syndrome","volume":"77","author":"Nigrovic","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_sbref9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1389710","article-title":"Heterogeneity of macrophage activation syndrome and treatment progression","volume":"15","author":"Dong","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102834_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/CCM.0000000000005361","article-title":"Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically ill children and adults","volume":"50","author":"Hines","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.coi.2026.102834_bib11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_sbref12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41390-024-03515-7","article-title":"Clinical and genetic analysis of macrophage activation syndrome complicating juvenile idiopathic inflammatory myopathies","volume":"97","author":"Li","year":"2025","journal-title":"Pediatr Res"},{"key":"10.1016\/j.coi.2026.102834_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00296-019-04442-1","article-title":"Macrophage activation syndrome in juvenile dermatomyositis: a systematic review","volume":"40","author":"Poddighe","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.coi.2026.102834_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-023-00893-w","article-title":"Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature","volume":"21","author":"Chang","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.coi.2026.102834_bib15","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2026.102834_bib16","unstructured":"Joanna B.: Institute. Critical appraisal tools. Available from: https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"10.1016\/j.coi.2026.102834_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"van der Heijde","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102834_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s13312-022-2606-2","article-title":"Juvenile dermatomyositis with macrophage activation and severe encephalopathy","volume":"59","author":"Jagwani","year":"2022","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.coi.2026.102834_bib19","article-title":"Anti-MDA5 positive juvenile dermatomyositis with macrophage activation syndrome: a case report","volume":"16","author":"Mehair","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.coi.2026.102834_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.autrev.2014.05.009","article-title":"A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria","volume":"13","author":"Poddighe","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2026.102834_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/03009742.2013.863968","article-title":"Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis","volume":"43","author":"Lilleby","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1409950","article-title":"Juvenile dermatomyositis with central nervous system involvement: two case reports from a retrospective single-center cohort, with literature review","volume":"12","author":"Yang","year":"2024","journal-title":"Front Pediatr"},{"key":"10.1016\/j.coi.2026.102834_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/24725625.2020.1832755","article-title":"Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report","volume":"5","author":"Quintana-Ortega","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.coi.2026.102834_bib24","first-page":"1014","article-title":"Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis","volume":"31","author":"Sterba","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-025-05336-6","article-title":"Anti-melanoma differentiation-associated gene 5 antibody-associated rapidly progressive interstitial lung disease in a pediatric patient: a case report","volume":"19","author":"Sirimontakan","year":"2025","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.coi.2026.102834_bib26","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1093\/rheumatology\/keaf225","article-title":"Long-term effectiveness and safety of baricitinib treatment on refractory or severe juvenile dermatomyositis","volume":"64","author":"Wang","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102834_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-024-00999-9","article-title":"Clinical characteristics and prognostic factors in juvenile dermatomyositis: data from the Spanish registry","volume":"22","author":"Carriqu\u00ed-Arenas","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.coi.2026.102834_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.8613","article-title":"A less common case of anti-MDA5 and anti-Ro52 antibody-positive juvenile dermatomyositis complicated with macrophage activation syndrome","volume":"12","author":"Zhang","year":"2024","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.coi.2026.102834_bib29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/mrcr\/rxac086","article-title":"Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: a case report","volume":"7","author":"Mouri","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.coi.2026.102834_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-022-00675-w","article-title":"Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review","volume":"20","author":"Stewart","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.coi.2026.102834_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/1756-185X.14258","article-title":"Janus kinase inhibition in induction treatment of anti-MDA5 juvenile dermatomyositis-associated rapidly progressive interstitial lung disease","volume":"25","author":"Chan Ng","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.coi.2026.102834_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4274\/turkderm.galenos.2022.72368","article-title":"Macrophage activation syndrome due to juvenile amyopathic dermatomyositis with atypical onset","volume":"56","author":"Y\u00fcksel","year":"2022","journal-title":"Turkderm Turk Ars"},{"key":"10.1016\/j.coi.2026.102834_bib33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2021.04.004","article-title":"Thrombotic microangiopathy associated with macrophage activation syndrome: a multinational study of 23 patients","volume":"235","author":"Minoia","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.coi.2026.102834_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/pch\/pxx209","article-title":"A 17-year-old girl with facial edema and weakness","volume":"23","author":"Deschamps","year":"2018","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.coi.2026.102834_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-015-0048-2","article-title":"Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels","volume":"13","author":"Wakiguchi","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.coi.2026.102834_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/s10165-012-0661-6","article-title":"Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review","volume":"23","author":"Yamashita","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2010.11.033","article-title":"Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis","volume":"158","author":"Kobayashi","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.coi.2026.102834_bib38","first-page":"489","article-title":"Dermatomyositis associated with hemophagocytic syndrome: a case report and review of the literature","volume":"38","author":"Sennaro\u011flu","year":"2008","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.coi.2026.102834_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4274\/jpr.53825","article-title":"Juvenile dermatomyositis with a rare and severe complication: macrophage activation syndrome","volume":"1","author":"\u00d6nen","year":"2014","journal-title":"J Pediatr Res"},{"key":"10.1016\/j.coi.2026.102834_bib40","first-page":"1838","article-title":"Clinical features of hemophagocytic syndrome in patients with dermatomyositis","volume":"35","author":"Yajima","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_bib41","first-page":"47","article-title":"Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis","volume":"77","author":"Bustos","year":"2012","journal-title":"An Pediatr"},{"key":"10.1016\/j.coi.2026.102834_bib42","article-title":"P12 a case of MDA5-positive juvenile dermatomyositis complicated by macrophage activation syndrome","volume":"6","author":"Twynam-Perkins","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.coi.2026.102834_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.coi.2026.102834_bib44","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/ard-2023-224123","article-title":"The 2022 EULAR\/American College of Rheumatology points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"82","author":"Hines","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102834_bib45","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.2020009499","article-title":"T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis","volume":"137","author":"Chaturvedi","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102834_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/OARRR.S151013","article-title":"Macrophage activation syndrome: early diagnosis is key","volume":"10","author":"Lerkvaleekul","year":"2018","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_bib47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.40417","article-title":"Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus","volume":"70","author":"Borgia","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_sbref47","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165616","article-title":"Type I interferon signature and cycling lymphocytes in macrophage activation syndrome","volume":"133","author":"Huang","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2026.102834_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/BOR.0000000000000634","article-title":"Interleukin-18 in pediatric rheumatic diseases","volume":"31","author":"Prencipe","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.coi.2026.102834_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41435-020-0098-4","article-title":"The genetics of macrophage activation syndrome","volume":"21","author":"Schulert","year":"2020","journal-title":"Genes Immun"},{"key":"10.1016\/j.coi.2026.102834_sbref50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.157070","article-title":"Distinct cytokine signature in juvenile dermatomyositis: linking myositis-specific antibodies and clinical manifestations","volume":"197","author":"Kaneko","year":"2026","journal-title":"Cytokine"},{"key":"10.1016\/j.coi.2026.102834_bib52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/rheumatology\/keaa299","article-title":"Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children","volume":"60","author":"Mizuta","year":"2021","journal-title":"Rheumatology"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:20:14Z","timestamp":1789089614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S0952791526001111"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102834","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of juvenile dermatomyositis complicated by macrophage activation syndrome","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102834"}}